1.
Determination of zidovudine stearate content in its liposomes
齐多夫定硬脂酸酯脂质体中药物含量的测定
2.
Comparative Study of Toxicity of Azidothymidine Myristate Liposome and Azidothymidine for Kunming Mice and Beagle Dogs
齐多夫定肉豆蔻酯脂质体与齐多夫定对实验动物毒性作用比较研究
3.
Studies in toxic effects of zidovudine on rat hepatocytes in primary culture
齐多夫定对原代大鼠肝细胞毒性作用的研究
4.
Simultaneous Determination of Zidovudine and Nevirapine in Human Plasma by HPLC-UV
高效液相色谱法同时测定人血浆中齐多夫定、奈韦拉平浓度
5.
Synthesis, Pharmacokinetics and Tissue Distributions of mPEG-AZT Conjugate;
齐多夫定—聚乙二醇缀合物的合成及药物动力学与组织分布学研究
6.
Effecting of Metal Ions on the Interaction between Zidovudine and Bovine Serum Albumin
金属离子对齐多夫定与牛血清白蛋白结合作用的影响
7.
Effects of Borneol on the Distribution of Azidothymidine Palmitate Liposomes in Mice
冰片对齐多夫定棕榈酸酯脂质体在小鼠体内分布的影响
8.
In August 2002, we had the domestically manufactured ARV drug, AZT, produced by Northeast Pharmaceuticals.
2002年8月，国产的第一个抗病毒药品齐多夫定在东北制药总厂被批准生产。
9.
The strong limit theorems for finite nonhomogeneous Markov chains;
有限非齐次马尔可夫链的强极限定理
10.
The strong law of large numbers of nonhomogeneous hidden Markov models
隐非齐次马尔可夫模型的强大数定律
11.
Application of Matrix Rank in Judging the Ergodicity of Homogeneous Markov Chains
矩阵秩在判定齐次马尔可夫链遍历性中的应用
12.
Strong Limit Theorem for the Hidden Nonhomogeneous Markov Model
关于非齐次隐马尔科夫模型的强极限定理
13.
Determination of Donepezil in Human Plasma by HPLC-ESI-MS
HPLC-ESI-MS测定人血浆中多奈哌齐的浓度
14.
On the Crime Judgment in the "Qieryao" Criminal Case
对“齐二药”案定性的多维视角分析
15.
Study of pharmacokinetics of AZT in mice by encapsulation in liposomes Containing galactosylceramide
齐多夫啶半乳糖神经酰胺脂质体在小鼠的药动学研究
16.
The Study of Encapsulation of Azidothymidine in Liposomes Containing Galactosylceramide and Its Pharmacokinetics;
齐多夫啶半乳糖神经酰氨脂质体的研制及药动学研究
17.
Study on Multi-Action Dynamic Maintenance Policy Based on Non-Homogeneous Markov Process;
基于非齐次马尔可夫过程的多动作动态维护策略研究
18.
Some Strong Deviation Theorems for Markov Chain Fields by a Kind of Non-Homogeneous Tree;
一类非齐次树上的马尔可夫链场的若干强偏差定理